BRILINTA 90 mg/1
Ticagrelor · TABLET · Aphena Pharma Solutions - Tennessee, LLC
Brilinta (ticagrelor) is a prescription tablet taken by mouth that helps prevent blood clots by blocking platelet activity, and it is commonly used in patients who have had a heart attack or acute coronary syndrome. This medication belongs to a class of drugs called P2Y12 platelet inhibitors.
Key Facts
- Brand Name
- BRILINTA
- Generic Name
- Ticagrelor
- NDC Code (Product)
71610-815- Manufacturer
- Aphena Pharma Solutions - Tennessee, LLC
- Strength
- 90 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- NDA022433
- Drug Class
- P2Y12 Platelet Inhibitor [EPC]
- Marketing Start
- 08/05/2011
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Frequently Asked Questions
What is BRILINTA used for?
Brilinta (ticagrelor) is a prescription tablet taken by mouth that helps prevent blood clots by blocking platelet activity, and it is commonly used in patients who have had a heart attack or acute coronary syndrome. This medication belongs to a class of drugs called P2Y12 platelet inhibitors.
Is BRILINTA a controlled substance?
BRILINTA is not classified as a controlled substance by the DEA.
What is the generic name for BRILINTA?
The generic name for BRILINTA is Ticagrelor. There are 12 other brand versions of Ticagrelor.
What is the NDC code for BRILINTA 90 mg/1?
The NDC (National Drug Code) for BRILINTA 90 mg/1 is 71610-815, listed by Aphena Pharma Solutions - Tennessee, LLC.